Clinical trial
Granuloma Annulare Treated With Rifampin, Ofloxacin, and Minocycline Combination Therapy
NCT00720980 is registered in ClinicalTrials.gov with Henry Ford Health System as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Granuloma Annulare Treated With Rifampin, Ofloxacin, and Minocycline Combination Therapy
- Lead sponsor
- Henry Ford Health System
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 31, 2008
- Completion date
- July 31, 2008
- Enrollment
- 6 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.